Vimarsana
Biggest News Aggregation in the World

Bleeding Events News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bleeding Events. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bleeding Events Today - Breaking & Trending Today

CNN CNN Newsroom With Pamela Brown July 6, 2024 - Vimarsana News

CNN CNN Newsroom With Pamela Brown July 6, 2024

top prize has exceeded 1 billion. the next drawing is tuesday, january 10th. good luck. the next hour of cnn "newsroom" starts right now. ♪ i'm pamela brown in washington. the top stories for you on this saturday night, republicans search for a path forward of what might be the craziest fight for house speaker ever. i'll talk to the congressman who nominated kevin mccarthy in that all important 15th vote. plus, new details as a virginia teacher lies in a hospital bed after police say she was shot by her 6-year-old student. as football evolves, so does its safety practices. ...

Enhancing Hemophilia A Adherence: Expert Insights - Vimarsana News

Enhancing Hemophilia A Adherence: Expert Insights

Lisa Schrade, PharmD, and Robert Sidonio Jr, MD, MSc, explore hemophilia A adherence and how specialty pharmacists can empower patients to take control of their healthcare through proactive engagement, personalized routines, and switching strategies when necessary.

Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial | JAMA - Vimarsana News

Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer: A Randomized Clinical Trial | JAMA

This randomized trial assesses the comparative effectiveness of direct oral anticoagulants vs low-molecular-weight heparin on rate of 6-month recurrence of veno

CNN CNN Newsroom With Pamela Brown June 4, 2024 00:47:00 - Vimarsana News

CNN CNN Newsroom With Pamela Brown June 4, 2024 00:47:00

Both groups, both the patients who received placebo and the patients who received the drug both showed progression of disease, but progression was slower in the patients who received the active treatment. as you said, there were some side effects to the drug. when you use sophisticated brain imaging, you can find brain abnormalities. there was some increased evidence of microscopic bleeding in some patients who received the active drug as well as some evidence of brain swelling that can be detected on brain imaging. large, clinically significant bleeding events were rare in both groups. so thi...